UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Neuropsychopharmacology (New York, N.Y.), 2007-04, Vol.33 (3), p.574-587

2007

Volltextzugriff (PDF)

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.17-34

2007

Volltextzugriff (PDF)

SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents

Pharmacology, biochemistry and behavior, 2012-08, Vol.102 (2), p.203-214

2012

Volltextzugriff (PDF)

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1995-11, Vol.352 (5), p.576-579

1995

Volltextzugriff (PDF)

Administration of amyloid β-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound

Neuroscience letters, 1996-08, Vol.213 (2), p.79-82

1996

Volltextzugriff (PDF)

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Pharmacology, biochemistry and behavior, 2008-11, Vol.91 (1), p.47-58

2008

Volltextzugriff (PDF)

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties

The Journal of pharmacology and experimental therapeutics, 2002-08, Vol.302 (2), p.731

2002

Volltextzugriff (PDF)

SR 46559A : a novel and potent muscarinic compound with no cholinergic syndrome

Psychopharmacologia, 1993-09, Vol.112 (2-3), p.219-227

1993

Volltextzugriff (PDF)

Cholinomimetic activities of minaprine

Naunyn-Schmiedeberg's archives of pharmacology, 1989-10, Vol.340 (4), p.411-418

1989

Volltextzugriff (PDF)

Stimulation of the [beta]3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Neuropsychopharmacology (New York, N.Y.), 2008-02, Vol.33 (3), p.574

2008

Volltextzugriff (PDF)

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders

Neuropsychopharmacology (New York, N.Y.), 2008-02, Vol.33 (3), p.574

2008

Volltextzugriff (PDF)

Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats

European journal of pharmacology, 1987-07, Vol.139 (1), p.111-116

1987

Volltextzugriff (PDF)

SSR180711, a Novel Selective 7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.17-34

2007

Volltextzugriff (PDF)

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.17

2007

Volltextzugriff (PDF)

SSRI80711, a novel selective α7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2007, Vol.32 (1), p.17-34

2007

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Animals
(11)
Rats
(10)
Male
(9)
Biological And Medical Sciences
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Medical Sciences
(7)
Mice
(7)
Pharmacology & Pharmacy
(7)
Psychology. Psychoanalysis. Psychiatry
(7)
Schizophrenia
(7)
Behavior, Animal - Drug Effects
(6)
Female
(5)
Neuropharmacology
(5)
Pharmacology. Drug Treatments
(5)
Rats, Sprague-Dawley
(5)
Rats, Wistar
(5)
Adult And Adolescent Clinical Studies
(4)
Memory
(4)
Neurosciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents

Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors

Administration of amyloid β-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic

SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties

SR 46559A : a novel and potent muscarinic compound with no cholinergic syndrome

Cholinomimetic activities of minaprine

Stimulation of the [beta]3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders

Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats

SSR180711, a Novel Selective 7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia

SSRI80711, a novel selective α7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia

Suchergebnisse filtern